Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with two medicines in combination
(fluconazole and flucytosine) is safe as compared with one medicine alone (fluconazole) for
the treatment of an early infection with a fungus called cryptococcus.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborators:
Bausch Health Americas, Inc. Kenya Medical Research Institute National Institute of Neurological Disorders and Stroke (NINDS) University of Nairobi Valeant Pharmaceuticals International, Inc.